Search in:

Diabetes, Metabolic Syndrome and Obesity Volume 11, 2018 - Issue

Submit an article Journal homepage

Open access

200

Views

CrossRef citations to date

Altmetric

Review

Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data

Anne J Kugler1 Department of Pharmacy Practice and Administration, Western University of Health Sciences College of Pharmacy, Pomona, CA, USACorrespondence[email protected]

Michael L Thiman2 Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Athens, GA, USA

Pages 187-197 | Published online: 09 May 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (16)

Hanan Abdel Moneam A. Shamardl, Noha A. Ibrahim, Dina H. Merzeban, Azza M. Elamir, Rehab M. Golam & Asmaa M. Elsayed. (2023) Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: Role of SIRT-1 / adipokines / PPARγ and IGF-1. DARU Journal of Pharmaceutical Sciences 31:1, pages 13-27.
Crossref

Victor Tran, Henry Tran, Shaban Demirel & Nathaniel Thompson-Moore. (2022) Impact of Glucagon-Like Peptide 1 Receptor Agonists in Patients with Hemoglobin A1c of 9% or Greater. Journal of Pharmacy Practice, pages 089719002210879.
Crossref

Xin Yi Yeo, Grace Cunliffe, Roger C. Ho, Su Seong Lee & Sangyong Jung. (2022) Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases. Biomedicines 10:2, pages 343.
Crossref

Sanjay Kalra, Saptarshi Bhattacharya & Nitin Kapoor. (2021) Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs). Diabetes Therapy 12:8, pages 2133-2147.
Crossref

Richard J MacIsaac. (2021) Glucagon-like peptide-1 receptor agonists and the cardiorenal axis in Type 2 diabetes: a focus on dulaglutide. Future Cardiology 17:3, pages 459-473.
Crossref

Juan P. Frias, Enzo Bonora, Luis Nevarez Ruiz, Ying G. Li, Zhuoxin Yu, Zvonko Milicevic, Raleigh Malik, M. Angelyn Bethel & David A. Cox. (2021) Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11). Diabetes Care 44:3, pages 765-773.
Crossref

Jee Hee YoonA Ram HongWonsuk ChoiJi Yong ParkHee Kyung KimHo-Cheol Kang. (2021) Real-World Efficacy and Safety of Dulaglutide in Korean Patients with Type 2 Diabetes Mellitus: A Retrospective Study in a Tertiary Referral Center. Chonnam Medical Journal 57:3, pages 211.
Crossref

Lixin Guo, Bin Zhang, Jianing Hou & Zhiguang Zhou. (2020) Evaluation of Characteristics of Gastrointestinal Adverse Events with Once-Weekly Dulaglutide Treatment in Chinese Patients with Type 2 Diabetes: A Post Hoc Pooled Analysis of Two Randomized Trials. Diabetes Therapy 11:8, pages 1821-1833.
Crossref

Richard J. MacIsaac. (2020) Dulaglutide and Insulin: How Can the AWARD Studies Help Guide Clinical Practice?. Diabetes Therapy 11:8, pages 1627-1638.
Crossref

Yu. Sh. Khalimov & V. G. Kuzmich. (2020) Organoprotective effects of glucagon-like peptide-1 receptor agonists with regard to findings of evidencebased cardiovascular safety studies. Medical Council:21, pages 189-197.
Crossref

Spyridon N. Karras, Theocharis Koufakis, Omar G. Mustafa & Kalliopi Kotsa. (2019) Anti‐incretin effect: The other face of Janus in human glucose homeostasis. Obesity Reviews 20:11, pages 1597-1607.
Crossref

Hongchao Pan, Yini Xie, Wenying Lu, Yin Chen, Zhao Lu, Jun Zhen, Weiwei Wang & Anquan Shang. (2019) Engineering an enhanced thrombin-based GLP-1 analog with long-lasting glucose-lowering and efficient weight reduction. RSC Advances 9:53, pages 30707-30714.
Crossref

Jee Hee Yoo, Yun Kyung Cho, Jiwoo Lee, Hwi Seung Kim, Yu Mi Kang, Chang Hee Jung, Joong-Yeol Park & Woo Je Lee. (2019) Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study. Diabetes Therapy 10:4, pages 1453-1463.
Crossref

Eiji Kutoh, Jyunka HayashiAlexandra N. Kuto. (2019) Efficacy and safety of dulaglutide in patients with absolute insulin deficiency. Endocrine Regulations 53:3, pages 187-190.
Crossref

Alena Adamíková. (2019) Dulaglutide‑pharmacological profile. Interní medicína pro praxi 21:1, pages 62-66.
Crossref

Andrei C. Sposito, Otávio Berwanger, Luiz Sérgio F. de Carvalho & José Francisco Kerr Saraiva. (2018) GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data. Cardiovascular Diabetology 17:1.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data

Articles from other publishers (16)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data

Citations (16)

Articles from other publishers (16)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date